Market Outlook

3 Millionaire Trading Challenge Student Reviews

10 February 2012 – 12:35 am PST

View Comments

3 Millionaire Trading Challenge Student Reviews

I LOVE posting feedback from my students, it makes me a better teacher, posts like this where 10 of my PennyStocking Silver students and TIMalert subscribers sent me their reviews. Pretty interesting to see some of the feedback I got … Continue reading → .

Continue reading...

(SBLK, USAK, LPSN) Stock in Focus by PennyOmega.com

10 February 2012 – 12:35 am PST

View Comments

Star Bulk Carriers Corp. (NASDAQ:SBLK) announced that it will release its results for the fourth quarter and year end 2011 after the market closes in New York on Wednesday, February 15, 2012. Star Bulk’s management team will host a conference call to discuss the Company’s financial results on Thursday, February 16, 2012, at 8:30 [Read [...]

Continue reading...

(BEBE, CRWE, NILE, PERF) Stock in Focus by PennyOmega.com

10 February 2012 – 12:35 am PST

View Comments

Bebe Stores, Inc. (Nasdaq:BEBE) announced that its Board of Directors declared bebe’s quarterly cash dividend of $0.025 per share. The dividend is payable on March 15, 2012 to shareholders of record at the close of business on March 1, 2012. bebe stores, inc. engages in the design, development, and production of women’s apparel and accessories. [...]

Continue reading...

(CRWE) Stock under Consideration by PennyOmega.com

10 February 2012 – 12:35 am PST

View Comments

Crown Equity Holdings Inc. (CRWE) Effective Video Marketing is a way of marketing products or services. There are millions of internet users watching submitted videos, so it is a great way to market your work-at-home business online. Benefits of using Effective Video Marketing include: a) Sales margins increase by properly structuring videos which puts more [...]

Continue reading...

Thoratec Reports Fourth Quarter and Full Year Fiscal 2011 Financial Results

10 February 2012 – 12:35 am PST

View Comments

  Revenue of $109.4 million for the fourth quarter and $422.7 million for the full year GAAP Net Income Per Diluted Share of $0.25 for the fourth quarter and $1.20 for the full year Non-GAAP Net Income Per Diluted Share of $0.38 for the fourth quarter and $1.56 for the full year PLEASANTON, Calif., Feb. [...]

Continue reading...

(PROJ, INTC, RBCN) PennyOmega.com Watch List for Friday Feb. 10, 2012

10 February 2012 – 12:35 am PST

View Comments

PROJ, Deltek, Inc. ** For the fourth quarter 2011, PROJ posted record product revenue of $28.9 million, up 12% compared to the same period the prior year, while its Non-GAAP operating income increased 46% year-over-year to $18.6 million. For the full year 2011, PROJ posted revenue of $341 million, a 22% increase compared to the [...]

Continue reading...

(TKMR, SPRT, THOR) PennyOmega.com Stocks In Action

10 February 2012 – 12:35 am PST

View Comments

TKMR, Tekmira Pharmaceuticals Corp. ** TKMR reported that the United States Patent & Trademark Office (USPTO) has recently issued two key patents expanding its intellectual property portfolio: one covers its lipid nanoparticle (LNP) delivery technology (U.S. Patent No. 8,058,069), and the other covers the chemical modification of siRNA to mitigate immune stimulation (U.S. Patent No. [...]

Continue reading...

Support.com Reports Fourth Quarter 2011 Financial Results

10 February 2012 – 12:35 am PST

View Comments

  REDWOOD CITY, CA — (CRWENEWSWIRE) – 02/08/12 – Support.com, Inc. (NASDAQ:SPRT), a leading provider of cloud-based technology services and software for consumers and small business, today reported unaudited financial results for its fourth quarter ended December 31, 2011. Q4 2011 Financial Summary For the fourth quarter of 2011, total revenue was $15.0 million compared [...]

Continue reading...

Tekmira Announces USPTO Issuance of Key Patents Broadly Covering LNP Formulations and Mitigation of Immune Stimulation

10 February 2012 – 12:35 am PST

View Comments

  VANCOUVER, BC, Feb. 9, 2012 (CRWENEWSWIRE) — Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM.TO), a leading developer of RNA interference (RNAi) therapeutics, announced today that the United States Patent & Trademark Office (USPTO) has recently issued two key patents expanding its intellectual property portfolio: one covers its lipid nanoparticle (LNP) delivery technology (U.S. Patent No. 8,058,069), [...]

Continue reading...

Exelixis Announces Fourth Quarter and Full Year 2011 Financial Results

10 February 2012 – 12:35 am PST

View Comments

  SOUTH SAN FRANCISCO, Calif — 02/08/2012 (CRWENEWSWIRE) — Exelixis, Inc. (Nasdaq:EXEL) today reported financial results for the fourth quarter and year ended December 31, 2011. Revenues for the fourth quarter ended December 31, 2011 were $93.3 million, compared to $40.8 million for the comparable period in 2010. The increase was primarily due to the [...]

Continue reading...